Latest Advocacy Group Content

Latest Content

Gavreto Approved by FDA to Treat Thyroid Cancer

December 1st 2020, 8:36pm

By Darlene Dobkowski, MA


The drug has been approved to treat patients with advanced or metastatic RET-mutant medullary thyroid cancer and RET fusion-positive thyroid cancer.

Higher Tumor Classification and Grade for Nonmuscle-Invasive Bladder Cancer May Increase Recurrence and Progression Risk Up to Five Years

December 1st 2020, 7:30pm

By Darlene Dobkowski, MA


Predicting risk for recurrence and progression in patients with nonmuscle-invasive bladder cancer may help when discussing management options with clinicians.

FDA Approves First PET Imaging Drug for Prostate-Specific Membrane Antigen Positive Lesions in Prostate Cancer

December 1st 2020, 7:02pm

By Darlene Dobkowski, MA


The radioactive diagnostic agent, Gallium 68 PSMA-11, can detect suspected prostate cancer metastasis or recurrence, providing another imaging option for these patients.

Cancer Burnout and The December Blues

December 1st 2020, 5:00pm

By Khevin Barnes


The holidays are different this year for everyone, but for patients with cancer and cancer survivors, the holidays in 2020 are a unique challenge that presents difficult thoughts to contemplate.

AI May Further Expand Prediction of Immunotherapy Response

December 1st 2020, 4:00pm

By Colleen Moretti


Machine learning may be used to predict disease progression in patients with advanced melanoma.

CURE®’s Top Stories: November 2020

December 1st 2020, 2:00pm

By Jessica Skarzynski


Each month, we take a look back at the most popular CURE® stories. Here are the top five stories for November 2020.

ALK+ Metastatic Non-Small Cell Lung Cancer: The Importance of Biomarker Testing

December 1st 2020, 5:00am

By Jonathan W. Riess, MD, MS, UC Davis Comprehensive Cancer Center


Black Women with Breast Cancer Experience More Treatment Delays, Prolonged Treatment Duration Compared With White Women

November 30th 2020, 10:00pm

By Darlene Dobkowski, MA


Several factors may lead to prolonged treatment duration for breast cancer including socioeconomic status, race, and barriers to care.

What Are Cancer Survivors, Patients and Caregivers Most Thankful for This Holiday Season?

November 30th 2020, 7:00pm

By Ryan McDonald


On social media, in honor of Thanksgiving, CURE® recently asked its readers to share what they are most thankful for this holiday season.

What To Do Next After Finding Out You Have Cancer

November 30th 2020, 5:00pm

By Jane Biehl Ph.D.


A cancer survivor shares some ways she coped when confronted with her cancer diagnosis.